Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Session 5 - Molecular tumour board (ESCAT criteria, performance data from molecular guided trials)

Functional interpretation of variants

Date

09 Oct 2022

Session

Session 5 - Molecular tumour board (ESCAT criteria, performance data from molecular guided trials)

Topics

Pathology/Molecular Biology;  Translational Research

Tumour Site

Presenters

A. H. Wagner, US

Resources

Login to access the resources on OncologyPRO.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.